Activest Wealth Management’s 10x Genomics TXG Stock Holding History

Activest Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$633	Hold	7	–	–	﹤0.01%	884
2026 Q2	$268	Buy	+7	New	+$183	﹤0.01%	1135
2025 Q4	–	Sell	-7	Closed	-$82	–	1304
2025 Q3	$82	Hold	7	–	–	﹤0.01%	1070
2025 Q2	$81	Sell	7 -134	-95%	-$1.22K	﹤0.01%	982
2025 Q1	$1.23K	Buy	141 +100	+244%	+$1.26K	﹤0.01%	741
2024 Q4	$589	Hold	41	–	–	﹤0.01%	514
2024 Q3	$926	Hold	41	–	–	﹤0.01%	461
2024 Q2	$797	Hold	41	–	–	﹤0.01%	445
2024 Q1	$1.54K	Hold	41	–	–	﹤0.01%	318
2023 Q4	$2.29K	Hold	41	–	–	﹤0.01%	266
2023 Q3	$1.69K	Hold	41	–	–	﹤0.01%	279
2023 Q2	$7.47K	Hold	41	–	–	0.01%	195
2023 Q1	$2.13K	Hold	41	–	–	﹤0.01%	252
2022 Q4	$1.49K	Hold	41	–	–	﹤0.01%	413
2022 Q3	$1K	Hold	41	–	–	﹤0.01%	422
2022 Q2	$2K	Hold	41	–	–	﹤0.01%	341
2022 Q1	$3K	Hold	41	–	–	﹤0.01%	287
2021 Q4	$6K	Hold	41	–	–	﹤0.01%	247
2021 Q3	$6K	Buy	+41	New	+$7.04K	﹤0.01%	276

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Activest Wealth Management's TXG Position: Q3 2026 in Review

Activest Wealth Management held its 10x Genomics (TXG) position steady in Q3 2026 at 7 shares worth $633. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Activest Wealth Management first reported a position in TXG in Q3 2021 and has held it in 19 quarters since. The position peaked at $7.47K in Q2 2023. 294 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

Activest Wealth Management held 7 shares of 10x Genomics worth $633 as of Q3 2026.
Activest Wealth Management left its 10x Genomics share count unchanged in Q3 2026.
10x Genomics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #884 holding.
Activest Wealth Management first reported a position in 10x Genomics in Q3 2021 and has held it in 19 quarters since.
Activest Wealth Management's 10x Genomics position peaked at $7.47K in Q2 2023.
294 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.